Peptidomimetics in Silico
- PMID: 32954671
- DOI: 10.1002/minf.202000087
Peptidomimetics in Silico
Abstract
Endogenous peptides as part of physiological processes are targets of interest when it comes to finding desirable therapeutics which are able to modulate molecular interactions. The major limits presented by peptides when they are used as drugs have motivated the research of the synthesis of peptidomimetics obtained through chemical modification and the use of in silico approaches. Here recent works on the discovery of peptidomimetics by computational methods are reported. Together with molecular dynamic simulations, the use of pharmacophore research simulations helps to gain insight into and understand the molecular determinants underlying the physiological processes.
Keywords: CADD; drugability; in silico peptidomimetics; peptides; pharmacophoric screening.
© 2020 Wiley-VCH GmbH.
References
-
- A. A. Ivanov, F. R. Khuri, H. Fu, Trends Pharmacol. Sci. 2013, 34, 393-400.
-
- M. M. Maslon, T. R. Hupp, Trends Cell Biol. 2010, 20, 542-555.
-
- W. Yu, A. D. MacKerell, Methods Mol. Biol. 2017, 1520, 85-106.
-
- T. Seidel, G. Ibis, F. Bendix, G. Wolber, Drug Discov. Today Technol. 2010, 7(4).
-
- G. Ballester, A. Carvajal, I. Devesa, B. Valenzuela, M. Duart, J. Ros, A. Montiel, Curr. Top. Pharmacol. 2011, 15(2).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources